Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Angiopoietin-1 variant reduces LPS-induced microvascular dysfunction in a murine model of sepsis.

Alfieri A, Watson JJ, Kammerer RA, Tasab M, Progias P, Reeves K, Brown NJ, Brookes ZL.

Crit Care. 2012 Oct 4;16(5):R182. doi: 10.1186/cc11666.

2.

Angiopoietin-1 regulates microvascular reactivity and protects the microcirculation during acute endothelial dysfunction: role of eNOS and VE-cadherin.

Alfieri A, Ong AC, Kammerer RA, Solanky T, Bate S, Tasab M, Brown NJ, Brookes ZL.

Pharmacol Res. 2014 Feb;80:43-51. doi: 10.1016/j.phrs.2013.12.008. Epub 2014 Jan 7.

PMID:
24407281
3.

Fixing the leak: targeting the vascular endothelium in sepsis.

Spicer A, Calfee CS.

Crit Care. 2012 Nov 21;16(6):177. doi: 10.1186/cc11829.

4.

Unraveling the mechanisms involved in endothelial barrier protective effects of angiopoietin-1 variant MAT.Ang-1.

Zhang RY, Min D, Wu J, Li L, Qu HP, Tang YQ.

Crit Care. 2012 Nov 27;16(6):466; author reply 466. doi: 10.1186/cc11844. No abstract available.

5.

Acute administration of recombinant Angiopoietin-1 ameliorates multiple-organ dysfunction syndrome and improves survival in murine sepsis.

David S, Park JK, Meurs Mv, Zijlstra JG, Koenecke C, Schrimpf C, Shushakova N, Gueler F, Haller H, Kümpers P.

Cytokine. 2011 Aug;55(2):251-9. doi: 10.1016/j.cyto.2011.04.005. Epub 2011 Apr 30.

PMID:
21531574
6.

Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction.

La Mura V, Pasarín M, Meireles CZ, Miquel R, Rodríguez-Vilarrupla A, Hide D, Gracia-Sancho J, García-Pagán JC, Bosch J, Abraldes JG.

Hepatology. 2013 Mar;57(3):1172-81. doi: 10.1002/hep.26127. Epub 2013 Jan 25.

PMID:
23184571
7.

Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusion in the iridial microvasculature during systemic inflammation.

Toguri JT, Moxsom R, Szczesniak AM, Zhou J, Kelly ME, Lehmann C.

Clin Hemorheol Microcirc. 2015;61(2):237-49. doi: 10.3233/CH-151996.

PMID:
26410875
8.

Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis.

Kümpers P, van Meurs M, David S, Molema G, Bijzet J, Lukasz A, Biertz F, Haller H, Zijlstra JG.

Crit Care. 2009;13(3):R64. doi: 10.1186/cc7866. Epub 2009 May 5.

9.

Regulation of angiopoietin expression by bacterial lipopolysaccharide.

Mofarrahi M, Nouh T, Qureshi S, Guillot L, Mayaki D, Hussain SN.

Am J Physiol Lung Cell Mol Physiol. 2008 May;294(5):L955-63. doi: 10.1152/ajplung.00449.2007. Epub 2008 Feb 29.

10.

Effect of deletion of cIAP2 on intestinal microcirculation in mouse endotoxemia and polybacterial sepsis.

Lehmann C, Zhou J, Schuster L, Götz F, Wegner A, Cerny V, Pavlovic D, Robertson GS.

Shock. 2014 May;41(5):454-7. doi: 10.1097/SHK.0000000000000132.

PMID:
24667612
11.
12.

Erythropoietin improves skeletal muscle microcirculation through the activation of eNOS in a mouse sepsis model.

Kao RL, Martin CM, Xenocostas A, Huang W, Rui T.

J Trauma. 2011 Nov;71(5 Suppl 1):S462-7. doi: 10.1097/TA.0b013e318232e7a2.

PMID:
22072004
13.

Neutrophil elastase inhibitor attenuates lipopolysaccharide-induced hepatic microvascular dysfunction in mice.

Ishii K, Ito Y, Katagiri H, Matsumoto Y, Kakita A, Majima M.

Shock. 2002 Aug;18(2):163-8.

PMID:
12166781
14.
15.

C1-inhibitor reduces hepatic leukocyte-endothelial interaction and the expression of VCAM-1 in LPS-induced sepsis in the rat.

Croner RS, Lehmann TG, Fallsehr C, Herfarth C, Klar E, Kirschfink M.

Microvasc Res. 2004 Mar;67(2):182-91.

PMID:
15020209
16.

Liver sinusoidal endothelial dysfunction after LPS administration: a role for inducible-nitric oxide synthase.

La Mura V, Pasarín M, Rodriguez-Vilarrupla A, García-Pagán JC, Bosch J, Abraldes JG.

J Hepatol. 2014 Dec;61(6):1321-7. doi: 10.1016/j.jhep.2014.07.014. Epub 2014 Jul 16.

PMID:
25038487
17.

Enhancement of muscle flap hemodynamics by angiopoietin-1.

Gurunluoglu R, Lubiatowski P, Goldman CK, Carnevale K, Siemionow M.

Ann Plast Surg. 2002 Apr;48(4):401-9.

PMID:
12068223
18.

Gene deletion of protein tyrosine phosphatase 1B protects against sepsis-induced cardiovascular dysfunction and mortality.

Coquerel D, Neviere R, Delile E, Mulder P, Marechal X, Montaigne D, Renet S, Remy-Jouet I, Gomez E, Henry JP, do Rego JC, Richard V, Tamion F.

Arterioscler Thromb Vasc Biol. 2014 May;34(5):1032-44. doi: 10.1161/ATVBAHA.114.303450. Epub 2014 Feb 27.

PMID:
24578383
19.
20.

Gene therapy by adenovirus-mediated vascular endothelial growth factor and angiopoietin-1 promotes perfusion of muscle flaps.

Lubiatowski P, Gurunluoglu R, Goldman CK, Skugor B, Carnevale K, Siemionow M.

Plast Reconstr Surg. 2002 Jul;110(1):149-59. Erratum in: Plast Reconstr Surg. 2003 Mar;111(3):1380..

PMID:
12087246

Supplemental Content

Support Center